申请人:BioChem Pharma, Inc.
公开号:US06444656B1
公开(公告)日:2002-09-03
The present invention relates to a novel nucleotide analogue having the general formula (I) and pharmaceutically acceptable salts, esters, or salt of such esters:
wherein n, X, Q U R1′, R1, Z and R2 are defined here within. The compounds object of the present invention may be a single enantiomers or as mixtures of said enantiomers, the compounds may have a &agr;D, &agr;-L, &bgr;-D, &bgr;-L, R or S configuration at each chiral center or mixtures thereof. This invention also relates to pharmaceutical compositions containing them, alone or in combination with other therapeutic agents, and their use as antiviral agents, particularly against HIV and/or HBV infections in mammals.
本发明涉及具有通式(I)的新型核苷类似物及其药用可接受的盐、酯或酯的盐:
其中n、X、Q、U、R1'、R1、Z和R2在此有定义。本发明的化合物可能是单对映体或所述对映体的混合物,该化合物在每个手性中心可能具有α-D、α-L、β-D、β-L、R或S构型或其混合物。本发明还涉及含有它们的药物组合物,单独或与其他治疗剂的组合物,并将它们用作抗病毒剂,特别是对抗哺乳动物体内的HIV和/或HBV感染。